These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26910333)

  • 21. Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality.
    Klouche K; Pommet S; Amigues L; Bargnoux AS; Dupuy AM; Machado S; Serveaux-Delous M; Morena M; Jonquet O; Cristol JP
    J Intensive Care Med; 2014; 29(4):229-37. PubMed ID: 23753226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
    Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
    Bargnoux AS; Kuster N; Patrier L; Dupuy AM; Tachon G; Maurice F; Badaoui B; Chalabi L; Badiou S; Deleuze S; Leray-Moragues H; Morena M; Canaud B; Cristol JP
    Clin Chem Lab Med; 2016 Apr; 54(4):673-82. PubMed ID: 26457775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.
    Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Ezekowitz MD; Hohnloser SH; Reilly PA; Vinereanu D; Siegbahn A; Yusuf S; Wallentin L
    Circulation; 2012 Apr; 125(13):1605-16. PubMed ID: 22374183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
    J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
    Morrow DA; de Lemos JA; Sabatine MS; Murphy SA; Demopoulos LA; DiBattiste PM; McCabe CH; Gibson CM; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2003 Apr; 41(8):1264-72. PubMed ID: 12706919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population.
    Bossard M; Thériault S; Aeschbacher S; Schoen T; Kunz S; von Rotz M; Estis J; Todd J; Risch M; Mueller C; Risch L; Paré G; Conen D
    Clin Res Cardiol; 2017 Feb; 106(2):96-104. PubMed ID: 27535138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
    Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB
    Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-sensitivity troponin T levels in kidney transplant recipients.
    Arroyo D; Quiroga B; Panizo N; Rodríguez-Ferrero M; Macías N; Reque J; Anaya F; Luño J
    Transplant Proc; 2012 Nov; 44(9):2545-7. PubMed ID: 23146449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.
    Kahveci G; Bayrak F; Mutlu B; Bitigen A; Karaahmet T; Sonmez K; Izgi A; Degertekin M; Basaran Y
    Am J Cardiol; 2007 May; 99(10):1429-33. PubMed ID: 17493474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Levels of Cardiac Troponin I in Subjects with Extremely Low B-type Natriuretic Peptide Levels.
    Sugawa S; Masuda I; Kato K; Yoshimura M
    Sci Rep; 2018 Mar; 8(1):5120. PubMed ID: 29572478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study.
    Venge P; Arnlöv J; Zethelius B
    Scand J Clin Lab Invest; 2009; 69(3):418-24. PubMed ID: 19221927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiomyocyte injury induced by hemodynamic cardiac stress: Differential release of cardiac biomarkers.
    Irfan A; Reichlin T; Twerenbold R; Fischer C; Ballarino P; Nelles B; Wildi K; Zellweger C; Rubini Gimenez M; Mueller M; Haaf P; Fischer A; Freidank H; Osswald S; Mueller C
    Clin Biochem; 2015 Dec; 48(18):1225-9. PubMed ID: 26129882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure.
    Horwich TB; Patel J; MacLellan WR; Fonarow GC
    Circulation; 2003 Aug; 108(7):833-8. PubMed ID: 12912820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical determinants of plasma cardiac biomarkers in patients with stable chest pain.
    Bing R; Henderson J; Hunter A; Williams MC; Moss AJ; Shah ASV; McAllister DA; Dweck MR; Newby DE; Mills NL; Adamson PD
    Heart; 2019 Nov; 105(22):1748-1754. PubMed ID: 31154425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
    J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy.
    Everett BM; Zeller T; Glynn RJ; Ridker PM; Blankenberg S
    Circulation; 2015 May; 131(21):1851-60. PubMed ID: 25825410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.